ZhangFKadierdingRZhangS, et al.Triglyceride glucose index for predicting major adverse cardiovascular events in Chinese patients with hypertension. Angiology. 2023;74:259–267.
2.
LiuYZhuBZhouW, et al.Triglyceride-glucose index as a marker of adverse cardiovascular prognosis in patients with coronary heart disease and hypertension. Cardiovasc Diabetol. 2023;22:133.
3.
TaoSYuLLiJ, et al.Association between the triglyceride-glucose index and 1-year major adverse cardiovascular events in patients with coronary heart disease and hypertension. Cardiovasc Diabetol. 2023;22:305.
4.
XiongSChenQZhangZ, et al.A synergistic effect of the triglyceride-glucose index and the residual SYNTAX score on the prediction of intermediate-term major adverse cardiac events in patients with type 2 diabetes mellitus undergoing percutaneous coronary intervention. Cardiovasc Diabetol. 2022;21:115.
5.
ZhaoJFanHWangT, et al.TyG index is positively associated with risk of CHD and coronary atherosclerosis severity among NAFLD patients. Cardiovasc Diabetol. 2022;21:123.
6.
MiaoMZhouGBaoA, et al.Triglyceride-glucose index and common carotid artery intima-media thickness in patients with ischemic stroke. Cardiovasc Diabetol. 2022;21:43.
7.
KhanSHSobiaFNiaziNK, et al.Metabolic clustering of risk factors: evaluation of triglyceride-glucose index (TyG index) for evaluation of insulin resistance. Diabetol Metab Syndrome. 2018;10:74.
8.
LiTWangPWangX, et al.Inflammation and insulin resistance in diabetic chronic coronary syndrome patients. Nutrients. 2023;15:2808.
9.
YangQVijayakumarAKahnBB. Metabolites as regulators of insulin sensitivity and metabolism. Nat Rev Mol Cell Biol. 2018;19:654–672.
10.
HillMAYangYZhangL, et al.Insulin resistance, cardiovascular stiffening and cardiovascular disease. Metabolism. 2021;119:154766.
